cls,trl_lbl,data_lvl,trials,n,m,s,q05,q95
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,agg,5,48377,65.0369872360592,8.587158888379015,51.27627774800905,79.34480532552305
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,ipd,1,5384,60.80492918429589,9.88187930853157,44.58712430589032,77.16228344611956
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,agg,8,54773,63.582799044636516,8.36374728711917,50.044737933331184,77.099974494749
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,ipd,1,9461,64.03170825346866,8.710973368966977,49.670660250233844,78.28441515915856
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,agg,5,37377,65.45915088864959,7.903735780972616,52.79676824318039,78.85348744588545
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,ipd,4,21608,61.08549082935043,9.029813070145728,45,75.50348929663235
Any,Total trials,agg,18,140527,64.58247643766514,8.362396919865338,51.06517956805175,78.40007952252819
Any,Total trials,ipd,6,36453,61.808713037470724,9.175302827975122,45,76.71934807760135
